GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma. Reply

N Engl J Med. 2023 Jun 15;388(24):2303-2304. doi: 10.1056/NEJMc2305296.

Authors

Concetta Quintarelli¹, Francesca Del Bufalo¹, Franco Locatelli¹

Affiliation

¹ IRCCS Bambino Gesù Children's Hospital, Rome, Italy franco.locatelli@opbg.net.

PMID: 37314725
DOI: 10.1056/NEJMc2305296

No abstract available

Publication types

Letter
Comment